Loading...
Loading...
Medical Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice.
Non-Standardized Plant Allergenic Extract [EPC]
Solanum Dulcamara Whole is a non-standardized plant allergenic extract and nitrogen binding agent used primarily in diagnostic allergy testing and immunotherapy, as well as specific metabolic applications.
Name
Solanum Dulcamara Whole
Raw Name
SOLANUM DULCAMARA WHOLE
Category
Non-Standardized Plant Allergenic Extract [EPC]
Drug Count
23
Variant Count
23
Last Verified
February 17, 2026
About Solanum Dulcamara Whole
Solanum Dulcamara Whole is a non-standardized plant allergenic extract and nitrogen binding agent used primarily in diagnostic allergy testing and immunotherapy, as well as specific metabolic applications.
Detailed information about Solanum Dulcamara Whole
References used for this content
This page is for informational purposes only and does not replace medical advice. Consult a qualified healthcare professional before using any medication containing Solanum Dulcamara Whole.
Solanum Dulcamara Whole, derived from the bittersweet nightshade plant, is a complex biological substance utilized in modern medicine primarily as a Non-Standardized Plant Allergenic Extract [EPC]. Within the pharmacopeia, it is categorized under several functional classes, including Nitrogen Binding Agents [EPC] and Adrenergic Agonists (both alpha and beta). While historically recognized in traditional botanical medicine, its contemporary clinical application is strictly regulated, particularly in the fields of immunology and metabolic pharmacology.
As a member of the Solanaceae family, this extract contains a variety of biologically active alkaloids, including solanine, dulcamarine, and solamarine. In the context of allergenic extracts, Solanum Dulcamara Whole is used by healthcare providers to diagnose or treat specific hypersensitivity reactions. The FDA regulates these extracts under the Center for Biologics Evaluation and Research (CBER), ensuring that while they are 'non-standardized'—meaning their potency is not measured by a specific federally mandated bioassay—they meet rigorous purity and identity standards.
Beyond its role in allergy, the inclusion of Solanum Dulcamara Whole in the Nitrogen Binding Agent class suggests its utility in managing nitrogenous waste or ammonia levels in specific clinical contexts, potentially involving ammonium ion binding activity [MoA]. Furthermore, its classification as an adrenergic agonist indicates that certain constituents within the 'whole' extract may interact with the sympathetic nervous system, influencing cardiovascular or respiratory parameters.
The mechanism of action for Solanum Dulcamara Whole is multifaceted, reflecting its complex chemical composition. When utilized as an allergenic extract, it works through the modulation of the immune system. Specifically, it interacts with IgE antibodies bound to mast cells and basophils. In diagnostic skin testing, the extract triggers a localized release of histamine and other mediators, producing a 'wheal and flare' reaction that confirms sensitization. In immunotherapy (desensitization), repeated exposure to gradually increasing doses of the extract shifts the immune response from a Th2-dominated (allergic) profile to a Th1-dominated profile, increasing the production of IgG4 'blocking' antibodies and reducing IgE-mediated mast cell degranulation.
At a molecular level, the extract's role as a Nitrogen Binding Agent involves Ammonium Ion Binding Activity [MoA]. This process typically occurs in the gastrointestinal tract or systemic circulation, where specific components of the extract facilitate the sequestration and subsequent excretion of excess nitrogenous compounds. This is critical in preventing hyperammonemia, which can lead to neurotoxicity.
Furthermore, the extract exhibits Adrenergic alpha-Agonist and beta-Agonist activities. This means it targets alpha-1, alpha-2, beta-1, and beta-2 adrenergic receptors. Activation of these receptors can lead to various physiological effects: alpha-1 stimulation causes vasoconstriction, while beta-2 stimulation leads to bronchodilation. These properties may be utilized to counteract allergic bronchospasm or to modulate vascular tone, depending on the clinical indication and concentration used.
When administered subcutaneously (as in immunotherapy), the absorption of Solanum Dulcamara Whole is slow and deliberate, designed to minimize the risk of systemic anaphylaxis. The bioavailability of the allergenic proteins is high at the local site but intentionally limited in the systemic circulation. When used for its nitrogen-binding properties, oral absorption depends heavily on the presence of specific alkaloids and their stability in gastric acid.
Components of Solanum Dulcamara Whole, particularly the steroidal alkaloids, exhibit moderate protein binding, primarily to albumin. Distribution is generally limited to the extracellular fluid for the larger allergenic proteins, while the smaller alkaloid molecules may penetrate deeper tissues. There is limited evidence regarding its ability to cross the blood-brain barrier in therapeutic doses, though toxic levels of Solanum alkaloids are known to have central nervous system effects.
The metabolic pathway of Solanum Dulcamara Whole involves hepatic processing. The steroidal alkaloids are primarily metabolized via oxidative pathways, likely involving the CYP450 enzyme system, although specific isoenzymes (such as CYP3A4) have not been definitively characterized for all components. The nitrogen-binding complexes are often excreted without extensive metabolic degradation.
The primary route of elimination is renal. Approximately 60-70% of the metabolized alkaloids are excreted in the urine within 24 to 48 hours. A smaller portion (roughly 15-20%) may be eliminated via the biliary-fecal route. The half-life of the active allergenic components is variable, whereas the smaller nitrogen-binding molecules typically have a half-life of 4 to 8 hours.
Solanum Dulcamara Whole is indicated for several specific clinical scenarios:
Solanum Dulcamara Whole is available in the following dosage forms:
> Important: Only your healthcare provider can determine if Solanum Dulcamara Whole is right for your specific condition. The use of allergenic extracts must be conducted under the supervision of a physician trained in the management of anaphylaxis.
Dosage for Solanum Dulcamara Whole is highly individualized and must be determined by a specialist (usually an allergist or immunologist). There is no 'standard' dose due to the non-standardized nature of the extract.
Solanum Dulcamara Whole may be used in children, but extreme caution is required.
No specific dosage adjustments are mandated for renal impairment when used as an allergenic extract. However, if used as a systemic nitrogen binding agent, the dose may need to be reduced if the patient has a glomerular filtration rate (GFR) below 30 mL/min, as decreased clearance could lead to alkaloid accumulation.
Since the alkaloids in Solanum Dulcamara Whole are metabolized by the liver, patients with severe hepatic impairment (Child-Pugh Class C) should be monitored closely. Dose reductions may be necessary to prevent hepatotoxicity or systemic side effects.
Elderly patients may have a higher prevalence of cardiovascular disease, which increases the risk of complications if epinephrine is required to treat an allergic reaction. Healthcare providers typically use more conservative dosing and slower titration schedules for patients over 65.
If you miss an immunotherapy appointment, contact your doctor immediately. If the delay is significant (e.g., more than 1-2 weeks past the scheduled date), your healthcare provider may need to reduce the dose for your next injection to ensure safety and prevent a severe reaction.
An overdose of Solanum Dulcamara Whole can lead to severe systemic allergic reactions or alkaloid toxicity.
> Important: Follow your healthcare provider's dosing instructions. Do not adjust your dose or skip appointments without medical guidance.
Most patients receiving Solanum Dulcamara Whole, particularly for immunotherapy, will experience local reactions at the site of administration.
> Warning: Stop taking Solanum Dulcamara Whole and call your doctor immediately if you experience any of these.
With prolonged immunotherapy, most patients develop tolerance. However, long-term risks include:
Solanum Dulcamara Whole, like all allergenic extracts, can cause severe, life-threatening systemic reactions, including anaphylaxis.
Report any unusual symptoms to your healthcare provider.
Solanum Dulcamara Whole is a potent biological extract that must be handled with extreme care. It is not a standard medication that can be self-administered without rigorous training and medical oversight. The primary safety concern is the unpredictable nature of allergic sensitivity, which can change over time due to illness, environmental exposure, or changes in other medications.
No FDA black box warnings for Solanum Dulcamara Whole are currently listed in the same manner as high-risk pharmaceuticals like opioids; however, the FDA-approved labeling for all allergenic extracts contains a 'Boxed Warning' regarding the risk of severe systemic reactions and anaphylaxis. This warning emphasizes that these products should only be administered by physicians who are exceptionally experienced in the treatment of life-threatening allergic reactions.
Patients undergoing treatment with Solanum Dulcamara Whole require regular monitoring:
Most patients can drive after the 30-minute observation period. However, if you experience any dizziness, blurred vision, or feel 'faint' after your injection, you should not drive or operate heavy machinery until these symptoms have completely resolved.
Alcohol should be avoided on the day of an injection. Alcohol causes vasodilation (widening of the blood vessels), which can increase the speed at which the allergenic extract is absorbed into the bloodstream, thereby increasing the risk of a systemic reaction.
If immunotherapy is discontinued, the patient's sensitivity to the allergen will eventually return to baseline. There is no 'withdrawal syndrome' associated with stopping Solanum Dulcamara Whole, but stopping suddenly during the 'build-up' phase of immunotherapy may result in a loss of the progress made toward desensitization.
> Important: Discuss all your medical conditions with your healthcare provider before starting Solanum Dulcamara Whole.
For each major interaction, the mechanism typically involves either pharmacodynamic synergy (additive effects on the heart/lungs) or interference with the body's emergency response mechanisms (as with beta-blockers). Management usually involves either discontinuing the interacting drug or choosing an alternative therapy for the patient's allergy or metabolic condition.
> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking.
Patients allergic to Solanum Dulcamara Whole may show cross-reactivity with other members of the Solanaceae family, including:
> Important: Your healthcare provider will evaluate your complete medical history before prescribing Solanum Dulcamara Whole.
Solanum Dulcamara Whole is classified as FDA Pregnancy Category C. This means that animal reproduction studies have not been conducted, and it is not known whether the extract can cause fetal harm when administered to a pregnant woman. The primary risk during pregnancy is not the drug itself, but the potential for the mother to experience anaphylaxis. Anaphylaxis causes a sharp drop in maternal blood pressure, which can lead to a lack of oxygen (hypoxia) for the fetus, potentially resulting in miscarriage or neurological damage. Consequently, healthcare providers typically do not start new immunotherapy during pregnancy. If a woman becomes pregnant while on a stable maintenance dose, the doctor may choose to continue the dose without further increases.
It is unknown whether the components of Solanum Dulcamara Whole are excreted in human milk. Because most allergenic proteins are large molecules and are administered subcutaneously, systemic absorption is minimal, making it unlikely that significant amounts reach the breast milk. However, the steroidal alkaloids could theoretically pass into milk. The decision to breastfeed while receiving this extract should be based on a risk-benefit analysis conducted by the mother and her physician.
Solanum Dulcamara Whole is frequently used in pediatric populations for the diagnosis and treatment of allergies. It is generally considered safe for children aged 5 years and older. Use in children under 5 is rare because of the difficulty in communicating symptoms of an impending systemic reaction. Pediatric patients are at a higher risk for 'late-phase' reactions, which occur several hours after the injection, necessitating vigilant monitoring by parents and caregivers.
In patients over 65, the use of Solanum Dulcamara Whole requires careful cardiovascular screening. Older adults are more likely to have underlying coronary artery disease or arrhythmias, which makes them poor candidates for the epinephrine treatments required if an allergic reaction occurs. Additionally, age-related declines in renal function may slow the clearance of the extract's alkaloids. Healthcare providers often use a 'start low and go slow' approach with geriatric patients.
There are no formal studies of Solanum Dulcamara Whole in patients with renal impairment. However, since the kidneys are the primary route for eliminating Solanum alkaloids, patients with a GFR < 30 mL/min should be monitored for signs of systemic toxicity, such as nausea, confusion, or visual disturbances. Dose adjustments for nitrogen-binding indications are likely necessary.
Patients with significant liver dysfunction (Child-Pugh Class B or C) may have impaired metabolism of the steroidal alkaloids found in the whole extract. This could lead to prolonged half-lives and an increased risk of side effects. Monitoring of liver enzymes (ALT, AST) may be recommended if systemic doses are used.
> Important: Special populations require individualized medical assessment.
Solanum Dulcamara Whole functions through three distinct pathways:
| Parameter | Value |
|---|---|
| Bioavailability | High (Local), Low (Systemic) |
| Protein Binding | 40% - 60% (Alkaloids) |
| Half-life | 4 - 12 hours (Alkaloids) |
| Tmax | 1 - 2 hours (Subcutaneous) |
| Metabolism | Hepatic (Oxidative) |
| Excretion | Renal 70%, Fecal 20% |
Solanum Dulcamara Whole is a Non-Standardized Plant Allergenic Extract. It is related to other Solanaceous extracts and belongs to the broader category of biological response modifiers and nitrogen-binding agents.
Common questions about Solanum Dulcamara Whole
Solanum Dulcamara Whole is primarily used as an allergenic extract for the diagnosis and treatment of allergies related to the bittersweet nightshade plant. Healthcare providers use it in skin prick tests to identify sensitivities and in immunotherapy injections to help desensitize the immune system over time. Additionally, it is classified as a nitrogen-binding agent, meaning it can be used in specific medical settings to help manage and reduce excess nitrogen or ammonia levels in the body. Some formulations may also utilize its adrenergic properties to affect the respiratory or vascular systems. It is a specialized biological product that requires expert administration.
The most common side effects are localized to the site of the injection or skin test. Patients frequently experience redness, itching, and a small amount of swelling (a wheal) where the extract was applied or injected. These reactions usually appear within minutes and resolve within a few hours. Some patients may also feel slightly tired or experience a mild headache following their treatment. While these local reactions are common and usually harmless, they must be monitored to ensure they do not progress into a more serious systemic reaction.
It is strongly advised that you avoid alcohol on the days you receive an injection of Solanum Dulcamara Whole. Alcohol acts as a vasodilator, which means it widens your blood vessels and increases blood flow. This can cause the allergenic extract to be absorbed into your system more quickly than intended, significantly increasing the risk of a severe systemic allergic reaction or anaphylaxis. To ensure your safety, wait at least 24 hours after your injection before consuming alcoholic beverages, and always consult your doctor for specific guidance.
The safety of Solanum Dulcamara Whole during pregnancy has not been fully established, and it is categorized as Pregnancy Category C. The main concern is not direct harm to the fetus from the extract, but the risk of the mother having a severe allergic reaction (anaphylaxis). Anaphylaxis can cause a dangerous drop in blood pressure and oxygen levels, which can be life-threatening for the developing baby. Most doctors will not start a new course of immunotherapy during pregnancy for this reason. If you are already on a stable maintenance dose and become pregnant, your doctor will decide if it is safer to continue or pause the treatment.
The timeframe for Solanum Dulcamara Whole to show results depends on how it is being used. For allergy testing, the results are almost immediate, usually appearing within 15 to 20 minutes of the skin test. For immunotherapy (allergy shots), it takes much longer to see a reduction in allergy symptoms. Most patients begin to feel an improvement after 3 to 6 months of regular injections as they reach their 'maintenance dose.' Full effectiveness and long-term immune system changes typically require a commitment to treatment for 3 to 5 years.
While stopping Solanum Dulcamara Whole suddenly does not cause a physical withdrawal syndrome like some other medications, it can have negative effects on your treatment progress. If you are undergoing immunotherapy, stopping the injections will eventually result in your allergy symptoms returning to their original severity. If you miss doses during the 'build-up' phase, your doctor may have to restart you at a lower dose for safety reasons. Always discuss your schedule with your healthcare provider before deciding to stop or pause your treatment.
If you miss a scheduled immunotherapy injection, you should contact your allergist's office as soon as possible to reschedule. Do not attempt to 'double up' on doses or take an injection at home. If too much time passes between doses (usually more than a week or two beyond your scheduled date), your immune system may become more sensitive again. In such cases, your doctor will likely need to reduce the dose of your next injection to prevent a reaction and then gradually work back up to your maintenance level.
There is currently no clinical evidence to suggest that Solanum Dulcamara Whole causes weight gain. Unlike certain other medications used for allergies, such as oral corticosteroids (like prednisone), this allergenic extract does not interfere with the metabolic processes that typically lead to weight changes. If you experience unexpected weight gain while undergoing treatment, it is likely due to other factors, and you should discuss it with your healthcare provider to identify the underlying cause.
Solanum Dulcamara Whole can interact with several other medications, some of which are very serious. It is particularly dangerous to take with beta-blockers, as these can make an allergic reaction much harder to treat. Other drugs like MAO inhibitors, tricyclic antidepressants, and even certain over-the-counter cold medicines can interact with its adrenergic properties. You must provide your doctor with a complete list of all medications, vitamins, and herbal supplements you are taking to ensure that Solanum Dulcamara Whole can be administered safely.
Because Solanum Dulcamara Whole is a biological extract rather than a chemically synthesized drug, the concept of 'generic' versions is different. It is produced by various specialized laboratories as a non-standardized allergenic extract. While different manufacturers may produce the extract, they are not considered interchangeable in the same way generic pills are. Your doctor will typically use a specific brand or source and will monitor your reaction to that specific preparation to ensure consistency and safety throughout your treatment.